Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Glioblastoma

Early Temferon Trial Shows Engineered Macrophages Reprogram Glioblastoma Niche to Rescue CAR-T Cells

Phase 1/2a testing confirmed safe tumor-targeted interferon-α delivery with clear evidence of microenvironment reprogramming.

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors